Arcutis Biotherapeutics, Inc. · NASDAQ:ARQT
Watanabe Todd sold 3,172 Arcutis Biotherapeutics, Inc. shares (Form 4)
Traded May 4, 2026 · Filed May 6, 2026
On May 4, 2026, Watanabe Todd (Director, See Remarks) sold 3,172 Arcutis Biotherapeutics, Inc. shares at US$23.61 for US$74,891 under a trading plan, leaving 720,755 shares. Filed May 6, 2026 (Form 4).
- Sold
- 3,172 shares
- Price
- US$23.61
- Value
- US$74,891
- Holding after
- 720,755 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, See Remarks
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 4, 2026 | Common Stock | Sale | 3,172 | US$23.61 | 720,755 | Direct |
Source
Related
- Arcutis Biotherapeutics, Inc.
- Watanabe Todd
- Arcutis Biotherapeutics, Inc. shareholders
- Form 4 · Watanabe Todd · Aug 5, 2026
- Form 4 · Welgus Howard G. · Oct 19, 2026
- Schedule 13G/A · BlackRock, Inc. · Oct 5, 2026
- Form 4 · Matsuda Masaru · Sep 18, 2026
- Form 4 · Welgus Howard G. · Sep 17, 2026
- Form 4 · Matsuda Masaru · Sep 10, 2026